Pangene Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.81 M
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
- Revenue Growth 69.14%
- Profit Growth 260.57%
- Ebitda 169.95%
- Net Worth 0.43%
- Total Assets 23.31%
About Pangene Biotech
Pangene Biotech Ltd (PBL) is a Public Limited Indian Non-Government Company incorporated in India on 05 July 2006 and has a history of 18 years and six months. Its registered office is in Kolkata, West Bengal, India.
The Corporate was formerly known as Pangene Biotech Pvt Ltd. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.81 M.
The company currently has active open charges totaling ₹2.00 M.
Debapriya Dasgupta, Amit Lahoti, and Anita Lahoti serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24234WB2006PLC110446
-
Company No.
110446
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
05 Jul 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
What products or services does Pangene Biotech Ltd offer?
Pangene Biotech Ltd offers a wide range of products and services, including Body Care Products, Body Lotions.
Who are the key members and board of directors at Pangene Biotech?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Debapriya Dasgupta | Director | 01-Nov-2021 | Current |
Anita Lahoti | Director | 26-Mar-2018 | Current |
Amit Lahoti | Director | 02-Apr-2007 | Current |
Financial Performance of Pangene Biotech.
Pangene Biotech Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 69.14% increase. The company also saw a substantial improvement in profitability, with a 260.57% increase in profit. The company's net worth moved up by a moderate rise of 0.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Pangene Biotech?
In 2022, Pangene Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.10 Cr
- Others : 0.10 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
25 Jul 2024 | Others | ₹1.00 M | Open |
26 Aug 2021 | Hdfc Bank Limited | ₹1.00 M | Open |
How Many Employees Work at Pangene Biotech?
Unlock and access historical data on people associated with Pangene Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pangene Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pangene Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.